| Product Code: ETC6738164 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, China continued to rely on imports of blood plasma derivatives, with top suppliers being Germany, Ireland, Switzerland, USA, and Metropolitan France. The market showed moderate concentration levels, indicating a competitive landscape. The compound annual growth rate (CAGR) from 2020 to 2024 was strong at 6.53%, with a notable growth spurt of 26.76% in 2024 alone. This suggests a growing demand for blood plasma derivatives in China, driving increased imports from key exporting countries.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Blood Plasma Derivative Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Blood Plasma Derivative Market Revenues & Volume, 2021 & 2031F |
3.3 China Blood Plasma Derivative Market - Industry Life Cycle |
3.4 China Blood Plasma Derivative Market - Porter's Five Forces |
3.5 China Blood Plasma Derivative Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Blood Plasma Derivative Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 China Blood Plasma Derivative Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Blood Plasma Derivative Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in China, leading to a higher demand for blood plasma derivatives. |
4.2.2 Growing awareness about the benefits of blood plasma derivatives in treating various medical conditions. |
4.2.3 Advancements in healthcare infrastructure and technologies supporting the production and distribution of blood plasma derivatives in China. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for blood plasma derivative products in China. |
4.3.2 Limited availability of donors and plasma collection centers, impacting the supply of blood plasma derivatives. |
4.3.3 Competition from alternative treatments and therapies affecting the market penetration of blood plasma derivatives in China. |
5 China Blood Plasma Derivative Market Trends |
6 China Blood Plasma Derivative Market, By Types |
6.1 China Blood Plasma Derivative Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Blood Plasma Derivative Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Blood Plasma Derivative Market Revenues & Volume, By Albumin, 2021- 2031F |
6.1.4 China Blood Plasma Derivative Market Revenues & Volume, By Factor VII, 2021- 2031F |
6.1.5 China Blood Plasma Derivative Market Revenues & Volume, By Factor IX concentrate, 2021- 2031F |
6.1.6 China Blood Plasma Derivative Market Revenues & Volume, By Anti-coagulation factor, 2021- 2031F |
6.1.7 China Blood Plasma Derivative Market Revenues & Volume, By Rh immunoglobulin, 2021- 2031F |
6.1.8 China Blood Plasma Derivative Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Blood Plasma Derivative Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Blood Plasma Derivative Market Revenues & Volume, By Immunodeficiency Diseases, 2021- 2031F |
6.2.3 China Blood Plasma Derivative Market Revenues & Volume, By Bleeding Disorders, 2021- 2031F |
6.2.4 China Blood Plasma Derivative Market Revenues & Volume, By Liver Conditions, 2021- 2031F |
6.2.5 China Blood Plasma Derivative Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Blood Plasma Derivative Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 China Blood Plasma Derivative Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 China Blood Plasma Derivative Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 China Blood Plasma Derivative Market Revenues & Volume, By Transfusion Centers, 2021- 2031F |
7 China Blood Plasma Derivative Market Import-Export Trade Statistics |
7.1 China Blood Plasma Derivative Market Export to Major Countries |
7.2 China Blood Plasma Derivative Market Imports from Major Countries |
8 China Blood Plasma Derivative Market Key Performance Indicators |
8.1 Number of plasma collection centers established or expanded in China. |
8.2 Percentage increase in the adoption of blood plasma derivative products in different medical facilities. |
8.3 Research and development investments in new blood plasma derivative therapies and technologies. |
8.4 Rate of regulatory approvals obtained for blood plasma derivative products in China. |
8.5 Patient outcomes and efficacy data for blood plasma derivative treatments. |
9 China Blood Plasma Derivative Market - Opportunity Assessment |
9.1 China Blood Plasma Derivative Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Blood Plasma Derivative Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 China Blood Plasma Derivative Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Blood Plasma Derivative Market - Competitive Landscape |
10.1 China Blood Plasma Derivative Market Revenue Share, By Companies, 2024 |
10.2 China Blood Plasma Derivative Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here